SecBot SecBot
8-K ·Filed Mar 9, 2026

LGVN

Longeveron Inc.
BEARISH
Impact 7/10
Horizonweeks Processed8mo ago SEC0001213900-26-024839
8-K context-dependent: Items 3.01, 5.02
Actionable Insight ▼ Bearish

Monitor for the appointment or shareholder nomination of a new audit committee financial expert within the next 180 days. Absent timely compliance, expect potential downgrades in liquidity and increased volatility. Consider exposure to micro-cap biotech governance risks.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$0.5300
T+0 close · Mar 9, 2026 · via day close
Latest settled
+43.40%
T+60 · $0.7600
Vs SPY
+31.41%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 9 $0.5300entry
  2. T+1 · 8mo ago +68.11%α +68.30% · $0.8910
  3. T+5 · 8mo ago +67.55%α +68.90% · $0.8880
  4. T+20 · 7mo ago +118.87%α +121.67% · $1.16
  5. T+60 · 6mo ago +43.40%α +31.41% · $0.7600
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Longeveron Inc. filed an 8-K disclosing that board member and audit committee financial expert Richard Kender resigned due to his new role at Seres Therapeutics, causing the company to fall out of Nasdaq compliance. The company appointed Dr. Roger Hajjar to the audit committee but still lacks a financial expert, triggering a delisting notice with a plan to appoint or elect a qualified director within 180 days.

Key Facts

  • Richard Kender resigned from the Board and Audit Committee effective March 3, 2026, due to his appointment as Executive Chairman and Interim CEO of Seres Therapeutics.
  • His resignation caused Longeveron to no longer comply with Nasdaq Listing Rule 5605(c)(2)(A), which requires at least three independent audit committee members, one of whom must be a financial expert.
  • The company appointed Dr. Roger Hajjar to the Audit Committee on March 4, 2026, restoring the three-member requirement but still lacking a financial expert.
  • Longeveron has a 180-day cure period to appoint or elect a director who qualifies as both independent and an audit committee financial expert.
  • Failure to regain compliance within 180 days could result in delisting from Nasdaq.

Financial Impact

High risk of delisting, which would reduce liquidity, limit institutional ownership, and increase cost of capital. No direct financial figures disclosed.

liquiditygovernancelisting statusinvestor confidence

Risk Factors

  • Risk of Nasdaq delisting if a financial expert is not appointed within 180 days
  • Reduced investor base and liquidity if delisted
  • Ongoing governance concerns due to weakened audit committee oversight

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-024839
Document: 0001213900-26-024839-index-headers.html0001213900-26-024839
Document: 0001213900-26-024839-index.html0001213900-26-024839
Document: 0001213900-26-024839.txt0001213900-26-024839

Track record

22 reports on LGVN

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +44.65% at T+20 after the Sep 16, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $2.53 Now $2.14 +15.42% settles Feb 12
  2. Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $2.49 Now $2.14 −14.06% settles Feb 11
  3. Nov 12, 20264d ago 8-K Bearish 7/10 No price data
  4. Nov 12, 20264d ago Press Release Bearish 6/10 Entry $2.49 Now $2.14 +14.06% settles Feb 11
  5. Nov 5, 202611d ago SC 13G/A Bearish 5/10 Entry $1.81 Now $2.14 −18.23% settles Feb 4
  6. Nov 5, 202611d ago 8-K Neutral 2/10 Entry $1.81 Now $2.14 +18.23% settles Feb 4
  7. Oct 26, 202621d ago 8-K Neutral 5/10 Entry $1.73 Now $2.14 +23.70% settles Jan 25
  8. Oct 26, 202621d ago Press Release Mixed 6/10 Entry $1.61 Now $2.14 +33.33% settles Jan 22
  9. Oct 14, 20264w ago 8-K Neutral 3/10 Entry $1.50 Now $2.14 +42.67% settles Jan 12
  10. Sep 16, 20268w ago Press Release Bearish 7/10 Entry $2.71 Now $2.14 +21.03% settles Dec 11
Showing 10 of 22

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 9, 2026